PT97876A - Processo para a producao de uma nova proteina - Google Patents

Processo para a producao de uma nova proteina

Info

Publication number
PT97876A
PT97876A PT97876A PT9787691A PT97876A PT 97876 A PT97876 A PT 97876A PT 97876 A PT97876 A PT 97876A PT 9787691 A PT9787691 A PT 9787691A PT 97876 A PT97876 A PT 97876A
Authority
PT
Portugal
Prior art keywords
protein
production
new protein
relates
malaria
Prior art date
Application number
PT97876A
Other languages
English (en)
Other versions
PT97876B (pt
Inventor
Johannes Gerardus Schoenmakers
Rodolph Nicolaas Hendr Konings
Inge Irma Maria Domini Moelans
Original Assignee
Univ Nijmegen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nijmegen filed Critical Univ Nijmegen
Publication of PT97876A publication Critical patent/PT97876A/pt
Publication of PT97876B publication Critical patent/PT97876B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT97876A 1990-06-06 1991-06-05 Processo para a producao de uma nova proteina PT97876B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909012580A GB9012580D0 (en) 1990-06-06 1990-06-06 Novel protein

Publications (2)

Publication Number Publication Date
PT97876A true PT97876A (pt) 1992-04-30
PT97876B PT97876B (pt) 1998-10-30

Family

ID=10677137

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97876A PT97876B (pt) 1990-06-06 1991-06-05 Processo para a producao de uma nova proteina

Country Status (16)

Country Link
EP (1) EP0597843B1 (pt)
JP (1) JP3066385B2 (pt)
KR (1) KR930700544A (pt)
AT (1) ATE176671T1 (pt)
AU (1) AU641779B2 (pt)
CA (1) CA2084673C (pt)
DE (1) DE69130895T2 (pt)
DK (1) DK0597843T3 (pt)
ES (1) ES2127728T3 (pt)
GB (1) GB9012580D0 (pt)
GR (1) GR3029665T3 (pt)
IE (1) IE911924A1 (pt)
NZ (1) NZ238401A (pt)
PT (1) PT97876B (pt)
WO (1) WO1991018922A1 (pt)
ZA (1) ZA914227B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9202026A (nl) * 1992-11-20 1994-06-16 Stichting Katholieke Univ Recombinant nuclëinezuur, daardoor gecodeerd polypeptide materiaal en daarop gebaseerd transmissie-blokkerend vaccin ter bestrijding van de malariaparasiet Plasmodium falciparum.
GB9616351D0 (en) * 1996-08-02 1996-09-11 Smithkline Beecham Biolog Vaccine composition
JP2001520048A (ja) 1997-10-20 2001-10-30 ジェンザイム トランスジェニックス コーポレイション 新規な改変されたＭＳＰ−１核酸配列並びに細胞システムにおいてｍＲＮＡレベル及び蛋白質発現を増大させる方法
US6828416B1 (en) 1998-08-21 2004-12-07 The United States Of America As Represented By The Department Of Health And Human Services Recombinant multivalent malarial vaccine against Plasmodium falciparum
GB0513421D0 (en) 2005-06-30 2005-08-03 Glaxosmithkline Biolog Sa Vaccines
AU2008288508B2 (en) 2007-08-13 2014-05-01 Glaxosmithkline Biologicals S.A. Vaccines
US20120244178A1 (en) * 2011-03-25 2012-09-27 Denise Doolan Plasmodium falciparum antigens

Also Published As

Publication number Publication date
ZA914227B (en) 1992-03-25
NZ238401A (en) 1994-01-26
ATE176671T1 (de) 1999-02-15
PT97876B (pt) 1998-10-30
IE911924A1 (en) 1991-12-18
AU641779B2 (en) 1993-09-30
WO1991018922A1 (en) 1991-12-12
CA2084673A1 (en) 1991-12-07
AU7962991A (en) 1991-12-31
KR930700544A (ko) 1993-03-15
DE69130895T2 (de) 1999-09-30
GR3029665T3 (en) 1999-06-30
JPH06500990A (ja) 1994-01-27
EP0597843B1 (en) 1999-02-10
EP0597843A1 (en) 1994-05-25
ES2127728T3 (es) 1999-05-01
DE69130895D1 (de) 1999-03-25
JP3066385B2 (ja) 2000-07-17
GB9012580D0 (en) 1990-07-25
CA2084673C (en) 2002-07-30
DK0597843T3 (da) 1999-09-20

Similar Documents

Publication Publication Date Title
CA2231603A1 (en) Chicken interleukin-15 and uses thereof
HUT37460A (en) Cloning dna for malaria antigens
ATE127345T1 (de) Stressproteine und verwendungen dafür.
DE3853139D1 (de) Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
DK0597843T3 (da) 16 kDa P. falciparum-overfladeprotein
IL97013A (en) Immunoreactive protein of an eimeria merozoite surface antigen, dna encodidng it, the production of the protein and its use as a vaccine
IL75788A (en) Peptide comprising a repeated sequence of four amino acids,which sequence occurs in plasmodium falciparum circumsporozoite protein
DE69635472D1 (de) Impfstoff gegen Geflügelkokzidose
IL90134A0 (en) Gene for encoding a human malaria vaccine antigen,malarial vaccines and pharmaceutical compositions
DK0709460T3 (da) Fjerkrævaccine imod coccidiosis
BR9604989A (pt) Polipeptídeos modificados para imunogenicidade aperfeiçoada e processo de sua produção
MY105313A (en) Malaria vaccine.
PT90739A (pt) Processo para a preparacao de uma proteina dotada de actividade de inibicao de trombina
ATE214097T1 (de) Die ansteckung blockierende malariaimpfstoffe
AR022662A1 (es) Acidos nucleicos y proteinas del gen mhp3 de mycoplasma hyopneumoniae y sus usos
DK1245677T3 (da) Nukleinsyrer og proteiner af Mycoplasma hyopneumoniae mhp3-genet og anvendelser deraf
DE69119230D1 (de) Schützende antikörper erregende plasmodium falciparum antigene und deren verwendung in impfstoffen
KR900701831A (ko) 열대열 말라리아 원충의 분열소체 표면 항원의 대립형질 변이주
PT93416A (pt) Processo para a preparacao de um polipeptido antigenico de rhoptries da forma merozoita de plasmodium, dos seus derivados e de composicoes imunogenicas que os contem
IL94063A0 (en) Plasmodium circumsporozoite protein analogs lacking repeat sequences and their expression by recombinant methods
AR245782A1 (es) Procedimiento para preparar gbp 130 h
AR027745A1 (es) Acidos nucleicos y proteinas del gen mhp3 de mycoplasma hyopneumoniae y sus usos
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19911206

FG3A Patent granted, date of granting

Effective date: 19980724

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000131